Journal of International Medical Research (Dec 2023)

Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism

  • Edgar Julián Reyes,
  • Paula Ruiz-Talero,
  • Mayra Alejandra Arenas,
  • Catalina Hernández-Flórez,
  • Oscar M Muñoz

DOI
https://doi.org/10.1177/03000605231219170
Journal volume & issue
Vol. 51

Abstract

Read online

Objective To identify factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer who present with venous thromboembolic disease (VTE). Methods In this prospective cohort, in-hospital and outpatient survival rates up to 180 days were analyzed using Kaplan–Meier curves. Cox regression was used to identify factors associated with different survival functions. Results One hundred patients were analyzed (median age, 67.5 years; 75% with Charlson index of <10; 69% with Eastern Cooperative Oncology Group (ECOG) score of 3–4). In-hospital mortality was 18%, and the median time from admission to death was 11 days (interquartile range, 1–61 days). Factors significantly associated with in-hospital mortality were the ECOG score and thrombocytopenia. The 180-day mortality rate was 52%, with deaths mainly occurring in the first 90 days since VTE diagnosis. Additional factors significantly associated with outpatient mortality included male sex and neoplasms with a high risk of thrombosis (lung, pancreas, stomach, uterus, bladder, and kidney neoplasms). Conclusion Patients with stage IV cancer and acute VTE have short survival. Poor prognostic factors are thrombocytopenia, the ECOG score, and certain types of cancer. These results may help physicians individualize decisions regarding initiation and continuation of anticoagulant therapy.